Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 22Myelodysplastic Syndromes 9Leukemia, Myelomonocytic, Acute 8Carcinoma, Non-Small-Cell Lung 7Leukemia, Myelomonocytic, Chronic 6Leukemia, Monocytic, Acute 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Leukemia 4Anemia, Refractory, with Excess of Blasts 4Myeloproliferative Disorders 3Leukemia, Promyelocytic, Acute 3Melanoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2GATA2 Deficiency 2Congenital Abnormalities 2Carcinoma, Renal Cell 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cytarabine 11tipifarnib 4Idarubicin 4Etoposide 4Sorafenib 3Bortezomib 3tanespimycin 2laromustine 2alvocidib 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Gene Expression Profiling 2Daunorubicin 2DNA Methylation 2Busulfan 2Azacitidine 2valspodar 1romidepsin 1ixabepilone 1fludarabine phosphate 1entinostat 1aldesleukin 1XK 469 1Watchful Waiting 1Vorinostat 1Observation 1Microarray Analysis 1Melphalan 1Lenalidomide 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Leukemia, Eosinophilic, Acute × Azacitidine × Clear all
NCT01260714 2015-08-20

Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
13 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00454480 2013-08-26

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

National Cancer Institute (NCI)

Phase 2/3 Completed
2,000 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡